MIM
HGEN

MetLife Investment Management’s HUMANIGEN, INC. HGEN Stock Holding History

MetLife Investment Management’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,193
Closed -$108K – 2576
2021
Q3 		$108K Hold
18,193
– – ﹤0.01% 2413
2021
Q2 		$316K Buy
+18,193
New +$332K ﹤0.01% 1853

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

MetLife Investment Management's HGEN Position: Q4 2021 in Review

MetLife Investment Management sold out of HUMANIGEN, INC. (HGEN) in Q4 2021, closing a stake of 18,193 shares — an estimated $108K sold.

MetLife Investment Management first reported a position in HGEN in Q2 2021 and held it in 2 quarters. The position peaked at $316K in Q2 2021. 89 funds tracked by Wall St. Rank hold HGEN as of Q4 2021.

  • MetLife Investment Management reported no remaining HUMANIGEN, INC. position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 18,193 HUMANIGEN, INC. shares in Q4 2021, an estimated $108K.
  • MetLife Investment Management first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 2 quarters.
  • MetLife Investment Management's HUMANIGEN, INC. position peaked at $316K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.